BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2125056)

  • 1. Ovarian stimulation in previous failures from in-vitro fertilization: distinction of two groups of poor responders.
    Tanbo T; Abyholm T; Bjøro T; Dale PO
    Hum Reprod; 1990 Oct; 5(7):811-5. PubMed ID: 2125056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG.
    Van der Elst J; Van den Abbeel E; Camus M; Smitz J; Devroey P; Van Steirteghem A
    Hum Reprod; 1996 Oct; 11(10):2097-106. PubMed ID: 8943509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian hyperstimulation for in vitro fertilization preceded by prolonged administration of a gonadotropin-releasing hormone agonist.
    Tanbo T; Dale PO; Abyholm T
    Acta Obstet Gynecol Scand; 1990; 69(4):333-7. PubMed ID: 2123069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human menopausal gonadotropin stimulation with and without clomiphene for in-vitro fertilisation in poor-responders.
    Oride A; Kanasaki H; Miyazaki K
    J Obstet Gynaecol; 2015 Feb; 35(2):163-7. PubMed ID: 25058620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/human menopausal gonadotrophin-stimulated cycles for in-vitro fertilization.
    Tanbo T; Dale PO; Abyholm T; Stokke KT
    Hum Reprod; 1989 Aug; 4(6):647-50. PubMed ID: 2506220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
    Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM
    Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of an in vitro fertilization program: two regimens of superovulation.
    Grochowski D; Wołczyński S; Kuczyński W; Kulikowski M; Szamatowicz M
    Gynecol Endocrinol; 1995 Mar; 9(1):59-62. PubMed ID: 7793301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
    MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
    N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders.
    Padilla SL; Dugan K; Maruschak V; Shalika S; Smith RD
    Fertil Steril; 1996 Apr; 65(4):796-9. PubMed ID: 8654641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization.
    Macnamee MC; Howles CM; Edwards RG; Taylor PJ; Elder KT
    Fertil Steril; 1989 Aug; 52(2):264-9. PubMed ID: 2502441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of buserelin acetate in an in vitro fertilization program: a comparison with classical clomiphene citrate-human menopausal gonadotropin treatment.
    Lejeune B; Barlow P; Puissant F; Delvigne A; Vanrysselberge M; Leroy F
    Fertil Steril; 1990 Sep; 54(3):475-81. PubMed ID: 2118860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of a short regimen of buserelin, a gonadotrophin-releasing hormone agonist, and human menopausal gonadotrophin in assisted conception cycles.
    Owen EJ; Davies MC; Kingsland CR; Jacobs HS; Mason BA
    Hum Reprod; 1989 Oct; 4(7):749-53. PubMed ID: 2514192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
    Dale PO; Tanbo T; Haug E; Abyholm T
    Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.
    Balen AH; Tan SL; MacDougall J; Jacobs HS
    Hum Reprod; 1993 Jun; 8(6):959-64. PubMed ID: 8345091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro fertilization with low-dose clomiphene citrate stimulation in women who respond poorly to superovulation.
    Awonuga AO; Nabi A
    J Assist Reprod Genet; 1997 Oct; 14(9):503-7. PubMed ID: 9401867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors affecting the results of in vitro fertilization--IV. Importance of the stimulation protocols combining GnRH analogs and HMG in women with unsuccessful stimulation with combinations of clomiphene citrate-HMG].
    Mardesic T; Müller P; Zetová L; Miková M; Stroufová A
    Ceska Gynekol; 1995 Apr; 60(2):74-8. PubMed ID: 7767590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a blocking vs. a flare-up protocol in poor responders with a normal and abnormal clomiphene citrate challenge test.
    Anserini P; Magnasco A; Remorgida V; Gaggero G; Testa D; Capitanio GL
    Gynecol Endocrinol; 1997 Oct; 11(5):321-6. PubMed ID: 9385531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the GnRH analogue buserelin for IVF--does it improve fertility?
    Shelton K; Fishel S; Jackson P; Webster J; Faratian B; Johnson J
    Br J Obstet Gynaecol; 1991 Jun; 98(6):544-9. PubMed ID: 1908314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
    Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
    Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.